Navidea Biopharmaceuticals Inc
F:NO1A

Watchlist Manager
Navidea Biopharmaceuticals Inc Logo
Navidea Biopharmaceuticals Inc
F:NO1A
Watchlist
Price: 0.046 EUR
Market Cap: 4.6m EUR

Wall Street
Price Targets

NO1A Price Targets Summary
Navidea Biopharmaceuticals Inc

There are no price targets for NO1A.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Navidea Biopharmaceuticals Inc Competitors:
Price Targets
688278
Xiamen Amoytop Biotech Co Ltd
22% Upside
ATRA
Atara Biotherapeutics Inc
16% Upside
RCKT
Rocket Pharmaceuticals Inc
131% Upside
BVXP
Bioventix PLC
115% Upside
HPHA
Heidelberg Pharma AG
134% Upside
068270
Celltrion Inc
23% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
27% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Navidea Biopharmaceuticals Inc

For the last 8 years the compound annual growth rate for Navidea Biopharmaceuticals Inc's revenue is -43%. The projected CAGR for the next 2 years is 261%.

-43%
Past Growth
261%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Navidea Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Navidea Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NO1A's stock price target?
Not Available

NO1A doesn't have any price targets made by Wall Street professionals.

What is Navidea Biopharmaceuticals Inc's Revenue forecast?
Projected CAGR
261%

For the last 8 years the compound annual growth rate for Navidea Biopharmaceuticals Inc's revenue is -43%. The projected CAGR for the next 2 years is 261%.

Back to Top